These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11163654)

  • 1. Development of natural immunity to Neisseria meningitidis.
    Pollard AJ; Frasch C
    Vaccine; 2001 Jan; 19(11-12):1327-46. PubMed ID: 11163654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningococci.
    Sippel JE
    Crit Rev Microbiol; 1981; 8(3):267-302. PubMed ID: 6781818
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro induction of memory-driven responses against Neisseria meningitidis by priming with Neisseria lactamica.
    Sánchez S; Troncoso G; Criado MT; Ferreirós C
    Vaccine; 2002 Jul; 20(23-24):2957-63. PubMed ID: 12126908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine prevention of meningococcal disease, coming soon?
    Morley SL; Pollard AJ
    Vaccine; 2001 Dec; 20(5-6):666-87. PubMed ID: 11738731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral immune responses to Neisseria meningitidis in children.
    Pollard AJ; Galassini R; van der Voort EM; Booy R; Langford P; Nadel S; Ison C; Kroll JS; Poolman J; Levin M
    Infect Immun; 1999 May; 67(5):2441-51. PubMed ID: 10225907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary and booster mucosal immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to university students in the United Kingdom.
    Zhang Q; Lakshman R; Burkinshaw R; Choo S; Everard J; Akhtar S; Finn A
    Infect Immun; 2001 Jul; 69(7):4337-41. PubMed ID: 11401971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinico-immunological characteristics in children given meningococcal group A polysaccharide vaccine developed at the G. N. Gabrichevskĭ Moscow Research Institute of Epidemiology and Microbiology].
    Skirda TA; Golovina LI; Mishina AI; Chernyshova TF; Savchenko LG; Chernyshova MS
    Pediatriia; 1992; (2):55-9. PubMed ID: 1513635
    [No Abstract]   [Full Text] [Related]  

  • 8. Review of meningococcal vaccines with emphasis on possible immunoprophylaxis of group B disease.
    Frøholm LO
    NIPH Ann; 1980 Dec; 3(2):67-74. PubMed ID: 6784045
    [No Abstract]   [Full Text] [Related]  

  • 9. Present status of polysaccharide vaccines in the prevention of meningococcal disease.
    Gold R; Lepow ML
    Adv Pediatr; 1976; 23():71-93. PubMed ID: 12651
    [No Abstract]   [Full Text] [Related]  

  • 10. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of polysaccharide vaccines for the prevention of meningococcal diseases.
    Gotschlich EC
    Monogr Allergy; 1975; 9():245-58. PubMed ID: 804088
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunoprophylaxis problem in meningococcal infection].
    Efimov DD; Belova TN
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Jul; (7):23-9. PubMed ID: 89767
    [No Abstract]   [Full Text] [Related]  

  • 13. [Human resistance to generalized bacterial infections (exemplified by meningococcal infection)].
    Platonov AE
    Vestn Ross Akad Med Nauk; 1999; (5):40-5. PubMed ID: 10394300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningococcal Group W Disease in Infants and Potential Prevention by Vaccination.
    Parikh SR; Campbell H; Beebeejaun K; Ribeiro S; Gray SJ; Borrow R; Ramsay ME; Ladhani SN
    Emerg Infect Dis; 2016 Aug; 22(8):1505-7. PubMed ID: 27433852
    [No Abstract]   [Full Text] [Related]  

  • 15. Can Neisseria lactamica antigens provide an effective vaccine to prevent meningococcal disease?
    Gorringe AR
    Expert Rev Vaccines; 2005 Jun; 4(3):373-9. PubMed ID: 16026250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary antibodies following parenteral immunization of infants with a meningococcal serogroup A and C conjugated vaccine.
    Borrow R; Fox AJ; Cartwright K; Begg NT; Jones DM
    Epidemiol Infect; 1999 Oct; 123(2):201-8. PubMed ID: 10579438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Meningococcal vaccines. Global epidemiological situation and strategies for prevention by vaccination].
    Rivero Calle I; Rodriguez-Tenreiro Sánchez C; Martinón-Torres F
    Enferm Infecc Microbiol Clin; 2015 Apr; 33(4):257-67. PubMed ID: 25795150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardisation and validation of serological assays for the evaluation of immune responses to Neisseria meningitidis serogroup A and C vaccines.
    Jodar L; Cartwright K; Feavers IM
    Biologicals; 2000 Sep; 28(3):193-7. PubMed ID: 10964447
    [No Abstract]   [Full Text] [Related]  

  • 19. Advances in the development of vaccines against Neisseria meningitidis.
    Tan LK; Carlone GM; Borrow R
    N Engl J Med; 2010 Apr; 362(16):1511-20. PubMed ID: 20410516
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of meningococcal group A and C polysaccharide vaccine on nasopharyngeal carrier state.
    Stroffolini T; Angelini L; Galanti I; Occhionero M; Congiu ME; Mastrantonio P
    Microbiologica; 1990 Jul; 13(3):225-9. PubMed ID: 2125684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.